Worldwide, alcohol abuse contributes to 50% of cirrhosis cases and 27% of liver-related mortality. Abuse of alcohol and other substances compromises all liver disease outcomes. Can better screening and treatment of substance abuse disorders in patients with liver disease improve clinical outcomes? Find out why multidisciplinary approaches between hepatologists and addiction teams is essential to achieve this goal.
- Recognize the rationale and need for an integrated care model to manage patients with alcohol-associated liver disease
- Review screening of and interventions for the management of alcohol and other substance use disorders in patients with alcohol-associated liver disease and to incorporate referral to relevant medical professionals for continuing treatment
- Identify research and funding opportunities on alcohol-associated liver disease and/or alcohol or other substance use disorders